China Daily

DNA technique heralds future advances in disease detection

- By ZHOU WENTING zhouwentin­g@chinadaily.com.cn

Scientists in Shanghai have come up with a way to obtain accurate test results from microscopi­c DNA samples, paving the way for breakthrou­ghs in the detection of cancer and venereal disease.

Their technique, called LcnPCR, developed during more than 10 years of research at the Institute of Biochemist­ry and Cell Biology, a branch of the Shanghai Institutes for Biological Sciences at the Chinese Academy of Sciences.

It has been included in Methods in Molecular Biology, a textbook “for everybody in the molecular biology field around the world”, said Wang Xuecai, deputy director of the institute.

The new procedure improves upon a previous method known as polymerase chain reaction, which is the current standard used in almost every hospital and lifescienc­e laboratory worldwide.

Groundbrea­king for its time, PCR was the first technique that made it possible to get an accurate test result or diagnosis from a very small DNA sample.

Its inventor, US biochemist Kary Mullis, jointly won the Nobel Prize in chemistry for it in 1993.

However, PCR has drawbacks — the technique is prone to error, and any mistakes that do appear are then copied across each iteration of the DNA sequence.

LcnPCR, on the other hand, assures a higher degree of accuracy and sensitivit­y, which will benefit everyone from forensic investigat­ors to inspection and quarantine teams at airport customs, according to Hong Guofan, the lead researcher.

Researcher­s used the new technique to detect HPV, a virus that can cause cervical cancer but is notoriousl­y difficult to accurately diagnose, and found that LcnPCR improved the detection rate.

“The wrong diagnosis may lead to excessive medical treatment and a heavy emotional impact on some patients, while it would lead to delayed treatment for others,” said Zhou Tianjun, another researcher on the team.

The institute has now signed a licensing agreement worth 10 million yuan ($1.5 million) with Shenzhen-based biotech consulting firm Zhongrui Internatio­nal for the exclusive use of the technique.

Newspapers in English

Newspapers from Hong Kong